−0.0029USD
−495.04 KUSD
2.76 KUSD
57.95 M
About Cell MedX Corp.
Sector
Industry
CEO
David M. Jeffs
Website
Headquarters
West Vancouver
Founded
2010
ISIN
US15115X1072
FIGI
BBG00475SGM2
Cell MedX Corp. is a biotech company, which engages in the discovery, development, and commercialization of therapeutic and non-therapeutic products that promote general wellness. Its products include Microcurrent Therapy and eBalance Systems. The company was founded on March 19, 2010, and is headquartered in Carson City, NV.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of CMXC is 0.05 USD — it has increased by 60.00% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Cell MedX Corp. stocks are traded under the ticker CMXC.
Yes, you can track Cell MedX Corp. financials in yearly and quarterly reports right on TradingView.
CMXC stock has risen by 60.00% compared to the previous week, the month change is a 128.57% rise, over the last year Cell MedX Corp. has showed a 4.80 M% increase.
Like other stocks, CMXC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Cell MedX Corp. stock right from TradingView charts — choose your broker and connect to your account.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Cell MedX Corp. EBITDA is −216.16 K USD, and current EBITDA margin is −16.21 K%. See more stats in Cell MedX Corp. financial statements.